News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,575 Results
Type
Article (8414)
Company Profile (141)
Press Release (479019)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (167431)
Career Advice (307)
Deals (25840)
Drug Delivery (7)
Drug Development (53898)
Employer Resources (14)
FDA (9861)
Job Trends (8646)
News (239902)
Policy (18103)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (517)
Accelerated approval (24)
ADA (18)
Adcomms (2)
Allergies (98)
Alliances (33350)
ALS (111)
Alzheimer's disease (994)
Antibody-drug conjugate (ADC) (271)
Approvals (10477)
Artificial intelligence (320)
ASCO (165)
Autoimmune disease (219)
Automation (28)
Bankruptcy (264)
Best Places to Work (7031)
BIO (37)
BIOSECURE Act (1)
Biosimilars (112)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (29)
Breast cancer (507)
Cancer (3691)
Cardiovascular disease (220)
Career advice (248)
Career pathing (1)
CAR-T (188)
Celiac Disease (1)
Cell therapy (508)
Cervical cancer (34)
Clinical research (48716)
Collaboration (1258)
Commercialization (3)
Company closure (1)
Compensation (1440)
Complete response letters (35)
COVID-19 (805)
CRISPR (64)
C-suite (745)
Cystic fibrosis (85)
Data (5726)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (346)
Diagnostics (4202)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73731)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88176)
Executive appointments (702)
FDA (12494)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (923)
Gene editing (126)
Generative AI (9)
Gene therapy (322)
GLP-1 (297)
Government (988)
Grass and pollen (2)
Guidances (282)
Healthcare (9386)
Hematology (95)
HIV (53)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (113)
Immuno-oncology (57)
Indications (162)
Infectious disease (997)
Inflammatory bowel disease (142)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (252)
Interviews (43)
IPO (12445)
IRA (2)
Job creations (1972)
Job search strategy (236)
JPM (1)
Kidney cancer (16)
Layoffs (66)
Legal (5217)
Licensing (7)
Liver cancer (45)
Longevity (16)
Lung cancer (510)
Lymphoma (258)
Machine learning (27)
Management (3)
Manufacturing (527)
Marketing (8)
MASH (118)
Medical device (8679)
Medtech (8819)
Mergers & acquisitions (14423)
Metabolic disorders (709)
mRNA (59)
Multiple sclerosis (122)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (38)
Neuroscience (1867)
NextGen: Class of 2026 (3181)
Non-profit (859)
Obesity (223)
Opinion (13)
Ovarian cancer (159)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (203)
Partnered (11)
Patents (467)
Patient recruitment (514)
Peanut (33)
People (41431)
Pharmaceutical (31)
Pharmacy benefit managers (8)
Phase 1 (15755)
Phase 2 (21810)
Phase 3 (14699)
Pipeline (7181)
Policy (19)
Postmarket research (1593)
Preclinical (6658)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (571)
Real estate (3028)
Recruiting (6)
Regulatory (14992)
Reports (21)
Research institute (603)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (122)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (6)
Startups (2038)
Stomach cancer (3)
Supply chain (50)
The Weekly (1)
Vaccines (332)
Venture capital (18)
Weight loss (74)
Women's health (78)
Date
Today (72)
Last 7 days (500)
Last 30 days (1614)
Last 365 days (19413)
2026 (11950)
2025 (19553)
2024 (23278)
2023 (26796)
2022 (34907)
2021 (37524)
2020 (33783)
2019 (23522)
2018 (17651)
2017 (18954)
2016 (18102)
2015 (24438)
2014 (21741)
2013 (18188)
2012 (20280)
2011 (20506)
2010 (20390)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (299)
Arkansas (11)
Asia (18256)
Australia (2136)
California (11852)
Canada (3117)
China (538)
Colorado (506)
Connecticut (406)
Delaware (208)
Europe (26052)
Florida (1770)
Georgia (371)
Hawaii (3)
Idaho (46)
Illinois (694)
India (49)
Indiana (320)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1222)
Massachusetts (7851)
Michigan (306)
Minnesota (558)
Mississippi (4)
Missouri (79)
Montana (22)
Nebraska (11)
Nevada (113)
New Hampshire (60)
New Jersey (2615)
New Mexico (12)
New York (2847)
North Carolina (1262)
North Dakota (4)
Northern California (5933)
Ohio (276)
Oklahoma (14)
Oregon (18)
Pennsylvania (2278)
Puerto Rico (20)
Rhode Island (31)
South America (408)
South Carolina (76)
South Dakota (1)
Southern California (4911)
Tennessee (119)
Texas (1909)
United States (38713)
Utah (358)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (915)
West Virginia (1)
Wisconsin (73)
487,575 Results for "immunome inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 6, 2026
August 7, 2026
·
1 min read
Press Releases
Immunomic Therapeutics Announces First Patient Dosed in Phase 1 Trial of Cancer Vaccine Candidate ITI-5000
July 20, 2026
·
2 min read
Press Releases
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 7, 2026
July 7, 2026
·
1 min read
Press Releases
HLB Subsidiary Immunomic Therapeutics Announces First Patient Dosed in Phase 1 Trial of Allergy Vaccine Candidate ITI-9001
July 2, 2026
·
2 min read
Press Releases
Immunome to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
May 27, 2026
·
1 min read
Press Releases
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 4, 2026
June 5, 2026
·
1 min read
Press Releases
Immunome Reports First Quarter 2026 Financial Results and Provides Business Update
May 13, 2026
·
8 min read
Press Releases
Immunome Announces U.S. FDA Acceptance of New Drug Application for Varegacestat for the Treatment of Adults with Desmoid Tumors
July 8, 2026
·
6 min read
Press Releases
Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-3050, an FAP-Targeted Radioligand Therapy, in Patients with FAP-Expressing Advanced Solid Tumors
July 20, 2026
·
4 min read
Cancer
Immunome Heads to the FDA With Desmoid Tumor Drug After Phase III Sweep
Varegacestat, a gamma secretase inhibitor, significantly improved progression-free survival while also meeting all key secondary endpoints in the pivotal RINGSIDE trial. Immunome is planning an FDA application for the second quarter of 2026.
December 15, 2025
·
2 min read
·
Heather McKenzie
1 of 48,758
Next
